2024
Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression
Rhee T, Shim S, Manning K, Tennen H, Kaster T, d’Andrea G, Forester B, Nierenberg A, McIntyre R, Steffens D. Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression. Psychotherapy And Psychosomatics 2024, 93: 8-23. PMID: 38272009, PMCID: PMC10880806, DOI: 10.1159/000535665.Peer-Reviewed Original ResearchConceptsCambridge Neuropsychological Test Automated BatteryAssessment of cognitive impairmentCognitive deficitsCognitive impairmentDepressive disorderNeuropsychological assessmentRemediation of cognitive impairmentAlleviation of depressive symptomsHealthy controlsEffect sizeTreatment-resistant depressionMajor depressive disorderDiagnosis of MDDModerate cognitive deficitsUnmedicated patientsHedges g standardized mean differencesDepressive symptomsMDDCompared to healthy controlsCognitive dysfunctionStandardized effect sizeStandardized diagnostic criteriaQuantify effect sizesDeficitsFixed- or random-effects model
2023
National Trends in Mental Health–Related Emergency Department Visits Among Youth, 2011-2020
Bommersbach T, McKean A, Olfson M, Rhee T. National Trends in Mental Health–Related Emergency Department Visits Among Youth, 2011-2020. JAMA 2023, 329: 1469-1477. PMID: 37129655, PMCID: PMC10155071, DOI: 10.1001/jama.2023.4809.Peer-Reviewed Original ResearchConceptsMental health-related ED visitsMental health-related visitsHealth-related visitsPediatric ED visitsSuicide-related visitsED visitsMental health-related emergency department visitsNational Hospital Ambulatory Medical Care SurveyAmbulatory Medical Care SurveyAverage annual percent changeYoung adultsEmergency department visitsDischarge diagnosis codesMental health service capacityMental health reasonsDiseases-Ninth RevisionAnnual percent changeLogistic regression analysisHealth service capacityNational probability sample surveySubstance use disordersMental health needsMental health problemsGreater increaseProbability sample survey
2022
Ketamine use in pediatric depression: A systematic review
Meshkat S, Rosenblat J, Ho R, Rhee T, Cao B, Ceban F, Danayan K, Chisamore N, Vincenzo J, McIntyre R. Ketamine use in pediatric depression: A systematic review. Psychiatry Research 2022, 317: 114911. PMID: 37732856, DOI: 10.1016/j.psychres.2022.114911.Peer-Reviewed Original ResearchConceptsSafety of ketamineRandomized clinical trialsPediatric depressionIntravenous ketamineNon-competitive N-methyl-D-aspartate (NMDA) receptor antagonistN-methyl-D-aspartate receptor antagonistSystematic reviewOpen-label trialSevere adverse eventsCommon psychiatric disordersDifferent administration modalitiesAdverse eventsAntidepressant effectsSignificant morbidityMean ageCase reportReceptor antagonistClinical trialsAdministration modalitiesDepressive symptomsPsychiatric disordersKetamine useElectronic databasesLarger sample sizeKetamine